XyloCor Therapeutics pulls in $22.6m

XyloCor Therapeutics, a gene therapy firm, has raised $22.6 million in funding.

XyloCor Therapeutics, a gene therapy firm, has raised $22.6 million in funding. Fountain Healthcare Partners led the round with participation from other investors that included Longwood Fund, Lumira Ventures, Sofinnova Investments and LSP.

Source: Press Release